An observational study of those who have been prescribed a GLP-1 agonist therapy (yet to commence), for either weight or diabetes management, and are willing to complete dietary records and questionnaires of behaviour and psychosocial health.
Forty individuals (20 for weight management, 20 for diabetes management) living in Australia who have been prescribed a GLP-1 agonist (no previous prescription or no use in the previous 6 months) will be recruited to participate over the initial 3 months of their treatment. Assessments will occur remotely (online) at baseline, 2 weeks, 1 month and 3 months. Optional body composition assessments will be provided at baseline and 3 months for those based in Melbourne, Australia.
Study Type
OBSERVATIONAL
Enrollment
37
Australian Catholic University
Fitzroy, Victoria, Australia
Feasibility of recruitment
The rate of recruitment and the retention rate of participants completing the dietary assessment measures.
Time frame: 4 months
Energy intake
Assessed using Intake24 records for at least 2 days per timepoint
Time frame: baseline, 2 weeks, 1 month, 3 months
Medication symptomology
Incidence of self-reported side effects
Time frame: baseline, 1 month, 3 months
Medication use
Dosage
Time frame: baseline, 1 month, 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.